Sio Gene Therapies Inc.
NASDAQ:SIOX
0.415 (USD) • At close July 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 1.883 | 0.336 | 5.542 | 12.606 | 21.287 | 11.448 | 8.058 | 8.244 | 6.407 | 5.058 | 5.194 | 10.92 | 8.267 | 6.833 | 21.09 | 7.149 | 21.483 | 21.502 | 37.418 | 21.799 | 37.346 | 38.555 | 43.712 | 40.798 | 36.63 | 32.074 | 25.276 | 23.435 | 34.324 | 8.277 | 10.608 |
| General & Administrative Expenses
| 2.6 | 2.941 | 2.992 | 0.47 | 4.086 | 9.748 | 3.859 | 3.965 | 4.198 | 4.491 | 4.64 | 5.133 | 5.409 | 5.051 | 6.468 | 6.157 | 10.933 | 10.622 | 11.754 | 2.244 | 18.032 | 30.112 | 21.518 | 12.299 | 11.342 | 9.449 | 12.631 | 7.154 | 28.23 | 3.76 | 17.376 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.6 | 2.941 | 2.992 | 0.47 | 4.086 | 9.748 | 3.859 | 3.965 | 4.198 | 4.491 | 4.64 | 5.133 | 5.409 | 5.051 | 6.468 | 6.157 | 10.933 | 10.622 | 11.754 | 2.244 | 18.032 | 30.112 | 21.518 | 12.299 | 11.342 | 9.449 | 12.631 | 7.154 | 28.23 | 3.76 | 17.376 |
| Other Expenses
| 0.464 | 0.197 | 0.124 | 0.047 | -0.076 | -0.03 | 0.02 | 8.971 | -0.098 | -0.58 | 2.066 | 0.127 | 0.694 | -0.56 | 1.097 | 5.891 | 0.078 | 0.315 | -0.668 | 0.535 | -0.55 | -0.131 | 0.357 | -0.369 | 47.972 | 41.523 | 37.907 | 0 | 62.554 | 0 | 0 |
| Operating Expenses
| 4.483 | 3.277 | 8.534 | 13.076 | 25.373 | 21.196 | 11.917 | 12.209 | 10.605 | 9.549 | 9.834 | 16.053 | 13.676 | 11.884 | 27.558 | 13.306 | 32.416 | 32.124 | 49.172 | 24.043 | 55.378 | 68.667 | 65.23 | 53.097 | 47.972 | 41.523 | 37.907 | 30.589 | 62.554 | 12.037 | 27.984 |
| Operating Income
| -4.62 | -3.143 | -8.534 | -13.279 | -25.449 | -21.196 | -11.917 | -12.209 | -10.605 | -9.549 | -9.834 | -16.053 | -13.676 | -11.884 | -27.558 | -13.306 | -32.416 | -32.124 | -49.172 | -24.043 | -55.378 | -68.667 | -65.23 | -53.097 | -47.972 | -41.523 | -37.907 | -30.589 | -62.554 | -12.037 | -27.984 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.601 | 0.063 | 0.124 | 0.242 | -0.076 | -0.03 | 0.02 | 8.971 | -0.098 | -0.58 | 2.066 | 0.127 | 0.694 | -0.56 | 1.097 | 5.891 | 0.078 | 0.315 | -0.668 | 0.535 | -0.55 | -0.131 | 0.357 | -0.369 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -4.019 | -3.08 | -8.41 | -13.037 | -25.456 | -21.237 | -11.898 | -3.239 | -10.704 | -10.13 | -8.564 | -16.366 | -14.048 | -13.757 | -28.019 | -9.137 | -34.244 | -33.741 | -51.81 | -25.351 | -57.878 | -70.676 | -66.747 | -54.609 | -47.972 | -41.523 | -37.907 | -30.589 | -62.554 | -12.037 | -27.984 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.601 | -0.063 | -0.004 | 0.287 | -0.069 | -0.019 | -0.028 | 0.092 | -0.188 | -0.146 | 0.03 | 0.282 | -0.009 | 0.127 | 0.038 | -0.091 | 0.052 | 0.094 | 0.078 | -0.032 | 0.024 | -1.59 | 2.519 | -1.776 | -0.161 | 0.729 | 0.148 | -0.918 | 0.802 | 0.024 | 0.074 |
| Net Income
| -3.418 | -3.017 | -8.406 | -13.324 | -25.456 | -21.237 | -11.87 | -3.331 | -10.516 | -9.984 | -8.594 | -16.648 | -14.039 | -13.884 | -28.057 | -9.046 | -34.296 | -33.835 | -51.888 | -25.319 | -57.902 | -69.086 | -69.266 | -52.833 | -47.811 | -42.252 | -38.055 | -29.671 | -63.356 | -12.061 | -28.058 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.046 | -0.041 | -0.11 | -0.18 | -0.35 | -0.29 | -0.16 | -0.05 | -0.2 | -0.21 | -0.2 | -0.67 | -0.62 | -0.61 | -1.23 | -0.45 | -2.13 | -2.24 | -3.85 | -1.88 | -4.3 | -5.14 | -5.21 | -4.26 | -3.86 | -3.41 | -3.07 | -2.39 | -5.11 | -0.97 | -2.8 |
| EPS Diluted
| -0.046 | -0.041 | -0.11 | -0.18 | -0.35 | -0.29 | -0.16 | -0.05 | -0.2 | -0.21 | -0.2 | -0.67 | -0.62 | -0.61 | -1.23 | -0.45 | -2.13 | -2.24 | -3.85 | -1.88 | -4.3 | -5.14 | -5.21 | -4.26 | -3.86 | -3.41 | -3.07 | -2.39 | -5.11 | -0.97 | -2.8 |
| EBITDA
| -4.483 | -3.277 | -8.263 | -13.029 | -25.255 | -21.114 | -11.787 | -3.238 | -10.703 | -9.507 | -6.849 | -15.21 | -12.133 | -11.71 | -25.666 | -7.415 | -32.338 | -31.196 | -48.806 | -22.538 | -54.865 | -68.083 | -64.538 | -53.466 | -47.959 | -41.523 | -37.896 | -30.583 | -62.554 | -12.024 | -27.984 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |